Washington G-2 Reports releases 2009 Laboratory market projections.
NEWARK, N.J., April 14 /PRNewswire/ -- A new study from market research firm Washington G-2 Reports indicates that the clinical diagnostic lab testing market will reach $98.4 billion in revenue by 2017. An increase in genetic testing, esoteric testing, consumer driven healthcare, aging demographics and expanded access to healthcare are among the key factors contributing to strong market growth.
Washington G-2 Reports' Lab Industry Strategic Outlook: Market Trends & Analysis 2009 also shows other key factors contributing to the rapid evolution of the clinical diagnostic lab testing industry -- for instance, the M&A wave that hit the industry over the past two years --settling in 2009. That's not to say that M&A will become obsolete. Together, Quest, LabCorp and Sonic Healthcare snapped up 21 acquisitions in 24 months. The three companies remain preoccupied with dominating specific geographic markets and Washington G-2 Reports expects they will monopolize the industry for some time to come.
In addition to providing critical insight into the U.S. clinical laboratory testing market through 2017 and critical data on M&A, Washington G-2 Reports' Lab Industry Strategic Outlook provides expert perspective on, how contemporary trends will shape the structure the growth of the laboratory industry. This includes comprehensive analysis of four key providers (hospital, independent laboratory, physician offices, and 'other' services) four primary markets (Medicare, Medicaid, esoteric testing, anatomic pathology and cytology, and workplace drug testing) and penetration into new markets.
Lab Industry Strategic Outlook: Market Trends & Analysis 2009 is rich with laboratory rankings, including the: Top 75 Hospital Labs; Top 100 Independent Laboratory Corporations, Top 100 Physician Office Lab
|SOURCE Washington G-2 Reports|
Copyright©2009 PR Newswire.
All rights reserved